Treadstone5 Jan 2016 09:58
Great buying today as well.
Anyone connected with Eli Lilly is good to have on board.
*Oxford BioMedica announced on 15 December 2015 that Lorenzo Tallarigo (experience includes: Intercept Pharmaceuticals, Genextra and Eli Lilly) has been appointed as Non-Executive Chairman of the Group and will join on 1 February 2016.